UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Impact of the 21-gene assay in decision-making during multidisciplinary breast meeting: A French experience

Gynécologie, obstétrique & fertilité, 2015-12, Vol.43 (12), p.780-785

2015

Volltextzugriff (PDF)

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Haematologica (Roma), 2010-03, Vol.95 (3), p.415-423

2010

Volltextzugriff (PDF)

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Haematologica (Roma), 2009-12, Vol.94 (12), p.1676-1681

2009

Volltextzugriff (PDF)

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Nature Medicine, 2020-03, Vol.26 (3), p.398-407

2020

Volltextzugriff (PDF)

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Cancer epidemiology, biomarkers & prevention, 2012-01, Vol.21 (1), p.134-147

2012

Volltextzugriff (PDF)

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Haematologica (Roma), 2012-02, Vol.97 (2), p.213-218

2012

Volltextzugriff (PDF)

Behavioral assessment of unilateral neglect: Study of the psychometric properties of the Catherine Bergego Scale

Archives of physical medicine and rehabilitation, 2003, Vol.84 (1), p.51-57

2003

Volltextzugriff (PDF)

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

Blood, 2005-05, Vol.105 (10), p.4035-4042

2005

Volltextzugriff (PDF)

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

Haematologica (Roma), 2011-07, Vol.96 (7), p.1059-1063

2011

Volltextzugriff (PDF)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Breast cancer research : BCR, 2020-01, Vol.22 (1), p.8-8, Article 8

2020

Volltextzugriff (PDF)

Comparison of radial forearm flap and thoracodorsal artery perforator flap donor site morbidity for reconstruction of oral and oropharyngeal defects in head and neck cancer

European annals of otorhinolaryngology, head and neck diseases, 2015-09, Vol.132 (4), p.185-189

2015

Volltextzugriff (PDF)

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

Blood, 2002-03, Vol.99 (5), p.1594-1601

2002

Volltextzugriff (PDF)

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Haematologica (Roma), 2010-06, Vol.95 (6), p.892-899

2010

Volltextzugriff (PDF)

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Blood, 2001-10, Vol.98 (8), p.2319-2325

2001

Volltextzugriff (PDF)

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9742-9754

2010

Volltextzugriff (PDF)

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies

American journal of human genetics, 2007-12, Vol.81 (6), p.1186-1200

2007

Volltextzugriff (PDF)

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Blood cancer journal (New York), 2017-06, Vol.7 (6), p.e568-e568

2017

Volltextzugriff (PDF)

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Breast cancer research : BCR, 2014-12, Vol.16 (6), p.3416-3416, Article 3416

2014

Volltextzugriff (PDF)

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk

PLoS genetics, 2013-03, Vol.9 (3), p.e1003173-e1003173

2013

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Aktive Filter

KollektionOvid

KollektionSpringerLink (Online service)

Nur zeigenMit Volltextzugriff

ThemaLife Sciences & Biomedicine

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)

Publikationsform

Artikel
(73)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(73)
Science & Technology
(73)
Female
(59)
Male
(54)
Adult
(50)
Aged
(47)
Hematology
(32)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Aged, 80 And Over
(23)
Oncology
(18)
Adolescent
(14)
Follow-Up Studies
(14)
Hematologic And Hematopoietic Diseases
(13)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(13)
Survival Rate
(13)
Risk Factors
(12)
Life Sciences
(11)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of the 21-gene assay in decision-making during multidisciplinary breast meeting: A French experience

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Behavioral assessment of unilateral neglect: Study of the psychometric properties of the Catherine Bergego Scale

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Comparison of radial forearm flap and thoracodorsal artery perforator flap donor site morbidity for reconstruction of oral and oropharyngeal defects in head and neck cancer

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk

Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

Aktive Filter

Suchergebnisse filtern